BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018

Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company said. DeFord originally joined Bard as science &tech VP in 2004, and had previously served life sciences managing director for venture capital fund Early Stage Partners and as prez &CEO of Cook Inc, which is now known as Cook Medical. He also currently serves on NuVasive‘s (NSDQ:NUVA) board of directors, BD said. “John is a recognized leader with more than 25 years of experience in the medical device industry, with expertise overseeing innovative R&D and technology-based initiatives that have made significant effects on saving and improving lives for patients around the world. He will drive organizational culture, capabilities, products and technology-enabled services to further strengthen the BD innovation funnel, while advancing the world of health through new innovations and solutions for our customers and patients,” prez Tom Polen said in a press release.  Teleflex global ops SVP Kennedy to retire next year Teleflex (NYSE:TFX) said last week that its global ops senior VP Thomas Kennedy will retire from the company at the end of next March. Kennedy will remain in his prese...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News bectondickinson Cook Medical crbard ectosense integer meddux Merit Medical Systems Inc. Nuvasive Optovue polarityte RenalGuard Solutions Teleflex Vital Connect Source Type: news

Related Links:

AbstractPurpose of ReviewThis review seeks to highlight the issue of when the best time to operate is given the neurocognitive consequences of pediatric OSA.Recent FindingsLearning and memory deficits persist after adenotonsillectomy in school age children with the disease at 9-month follow-up, suggesting short-term damage to the hippocampus in young children with OSA.SummaryLarger trials with younger children with pediatric OSA are currently ongoing to evaluate the impact of adenotonsillectomy on learning and memory recovery.
Source: Current Anesthesiology Reports - Category: Anesthesiology Source Type: research
Abstract Background: Obstructive sleep apnea (OSA) is a common disease. It can cause many serious complications. OSA may increase the risk of hypertension. However, the exact mechanism of OSA causing hypertension is not fully understood. YKL-40/chitinase-3-like protein-1 plays an important role in vascular injury, repair, and generation. We sought to explore the role of YKL-40 in endothelial dysfunction and hypertension in OSA patients. Methods: All subjects were examined by polysomnography (PSG) and the expression of YKL-40 in the plasm of the subjects was measured by luminex. Carotid intima-media thickness ...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Obese people with sleep apnea may live longer with positive airway pressure (PAP) therapy, a recent study suggests.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Authors: Bilotta F, Giordano G, Pugliese F PMID: 30997176 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
Comment to the Editorial by KS Park and EW Kang "Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstructive sleep apnea?" J Thorac Dis. 2019 Mar;11(Suppl 3):S480-S482 Authors: Marrone O, Cibella F, Pépin JL, Grote L, Verbraecken J, Saaresranta T, Kvamme JA, Basoglu OK, Lombardi C, McNicholas WT, Hedner J, Bonsignore MR PMID: 30997253 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
Authors: Kalkbrenner C, Brucher R, Kesztyüs T, Eichenlaub M, Rottbauer W, Scharnbeck D Abstract The current gold standard for assessment of most sleep disorders is the in-laboratory polysomnography (PSG). This approach produces high costs and inconveniences for the patients. An accessible and simple preliminary screening method to diagnose the most common sleep disorders and to decide whether a PSG is necessary or not is therefore desirable. A minimalistic type-4 monitoring system which utilized tracheal body sound and actigraphy to accurately diagnose the obstructive sleep apnea syndrome was previously develo...
Source: GMS German Medical Science - Category: General Medicine Tags: Ger Med Sci Source Type: research
This study aimed to examine the prevalence of REM-related OSA in narcolepsy patients. Methods From January 2013 to April 2018, 141 adult patients were diagnosed with narcolepsy using nocturnal polysomnography and the multiple sleep latency test. The prevalence of REM-related OSA in narcolepsy patients was retrospectively reviewed. Three criteria were used to determine REM-related OSA: Definition #1, an overall apnea-hypopnea index (AHI) ≥5 and AHI during REM (AHIREM)/AHI during non-rapid eye movement (NREM) (AHINREM) ≥2; Definition #2, an overall AHI ≥5 and AHIREM/AHINREM≥2 and AHINREM
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Authors: Song SO, He K, Narla RR, Kang HG, Ryu HU, Boyko EJ Abstract Obstructive sleep apnea (OSA) and diabetes has been known to be closely related to each other and both diseases impact highly on the public health. There are many evidence of reports that OSA is associated with diabetes with a bidirectional correlation. A possible causal mechanism of OSA to diabetes is intermittent hypoxemia and diabetes to OSA is microvascular complication. However, OSA and diabetes have a high prevalence rate in public and shares the common overlap characteristic and risk factors such as age, obesity, and metabolic syndrome that...
Source: Diabetes and Metabolism Journal - Category: Endocrinology Tags: Diabetes Metab J Source Type: research
Decision Resources Group (DRG) released a new report today, "4 Crazy Medtech Innovations" that identifies four areas of medtech innovation that are forecasted to shake up the treatment landscape within the next five years. "The reason we decided to look at crazy innovation in medtech was that a few people on our consulting team were doing that and to help them out we decided to do a scan talking to our different data experts, therapy experts, [to learn] what have people seen that's actually crazy innovation," Lexie Code, director of medtech learning at DRG, told MD+DI. After gathering intel from each of...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news
(Reuters Health) - Obese people with sleep apnea, a common nighttime breathing disorder, may live longer when they use a machine to help keep their airways open while they sleep, a recent study suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Belgium Health | Environmental Health | Jordan Health | Marketing | Medical Devices | Middle East Health | Opthalmology | Orthopaedics | Respiratory Medicine | Science | Sleep Apnea | Sleep Disorders | Sleep Medicine | Venture Capital